5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.90▼ | 5.86▲ | 5.87▲ | 6.19▼ | 6.81▼ |
MA10 | 5.87▲ | 5.88▲ | 5.98▼ | 6.69▼ | 5.39▲ |
MA20 | 5.88▼ | 6.06▼ | 6.20▼ | 6.98▼ | 3.08▲ |
MA50 | 6.13▼ | 6.20▼ | 6.46▼ | 5.11▲ | 1.69▲ |
MA100 | 6.20▼ | 6.73▼ | 7.01▼ | 2.95▲ | 3.19▲ |
MA200 | 6.71▼ | 7.06▼ | 7.13▼ | 1.82▲ | 12.43▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.021▲ | -0.013▼ | -0.017▼ | -0.331▼ | 0.472▲ |
RSI | 44.227▼ | 40.530▼ | 37.788▼ | 41.399▼ | 66.670▲ |
STOCH | 47.222 | 40.014 | 29.188 | 20.343 | 78.579 |
WILL %R | -64.286 | -65.854 | -72.000 | -83.843▼ | -35.323 |
CCI | 4.439 | -25.257 | -59.860 | -126.648▼ | 45.224 |
Saturday, February 27, 2021 12:25 PM
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and fast, with a skew of small and midcap companies releasing their ...
|
Friday, February 26, 2021 08:42 AM
Acorda Therapeutics (NASDAQ:ACOR) is scheduled to issue its quarterly earnings data after the market closes on Thursday, March 4th. Analysts expect the company to announce earnings of ($2.57) per ...
|
Thursday, February 25, 2021 07:09 AM
Acorda Therapeutics announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
26/02/21 | 6.05 | 6.0721 | 5.65 | 5.82 | 149,081 |
25/02/21 | 6.35 | 6.45 | 6.02 | 6.05 | 203,659 |
24/02/21 | 6.48 | 6.83 | 6.18 | 6.33 | 230,720 |
23/02/21 | 6.20 | 6.20 | 5.371 | 6.14 | 434,352 |
22/02/21 | 6.63 | 6.79 | 6.52 | 6.61 | 203,465 |
19/02/21 | 6.90 | 6.92 | 6.58 | 6.63 | 270,343 |
18/02/21 | 7.24 | 7.355 | 6.88 | 6.88 | 288,660 |
17/02/21 | 7.36 | 7.45 | 7.16 | 7.42 | 214,000 |
16/02/21 | 7.62 | 7.7452 | 7.32 | 7.45 | 424,110 |
12/02/21 | 7.65 | 7.80 | 7.47 | 7.53 | 160,243 |
|
|
||||
|
|
||||
|
|